Protamine Sulfate Injection, Solution
Product Images NDC 63323-229

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Protamine Sulfate (NDC 63323-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Address (Pro2a 0000 01)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Protamine Sulfate Injection USP 250 mg per 25 mL (10 mg per mL) in a 25 mL single dose vial. The label states 'For Intravenous Use Only', indicates the product is sterile, nonpyrogenic, preservative free, and provides storage and usage instructions. It is manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Protamine Sulfate Injection, USP 10 mg/mL (250 mg per 25 mL) single-dose vial label. The label states preservative-free sterile solution for intravenous use, supplied by Fresenius Kabi USA, LLC. Storage instructions specify 20° to 25°C (68° to 77°F) with no freezing allowed. Contains detailed ingredients, dosage form, and manufacturer information along with a barcode.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Protamine Sulfate Injection, USP with strength 10 mg/mL (50 mg per 5 mL). The label states it is for intravenous use only, sterile, preservative-free, supplied in a 5 mL single-dose vial. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. Includes NDC 63323-229-01 and barcode.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Protamine Sulfate Injection, USP 50 mg per 5 mL (10 mg per mL) by Fresenius Kabi USA, LLC. The label specifies intravenous use only and includes a 25 x 5 mL single dose vial count. It lists inactive ingredients, directions for use, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.